Mostrar el registro sencillo del ítem

dc.contributor.authorValero Juan, Margarita 
dc.contributor.authorCosta, S.M.B.
dc.contributor.authorAscenso, José R.
dc.contributor.authorVelázquez Salicio, María Mercedes 
dc.contributor.authorRodríguez Hernández, Licesio Jesús
dc.date.accessioned2026-04-21T07:15:53Z
dc.date.available2026-04-21T07:15:53Z
dc.date.issued1999
dc.identifier.citationValero, M., Costa, S. M. B., Ascenso, J. R., Velázquez, M. M., & Rodríguez, L. J. (1999). Complexation of the non-steroidal anti-inflammatory drug Nabumetone with modified and unmodified cyclodextrins. Journal of Inclusion Phenomena, 35(4), 663-677. https://doi.org/10.1023/A:1008011228459es_ES
dc.identifier.issn1388-3127
dc.identifier.urihttp://hdl.handle.net/10366/171051
dc.description.abstract[EN]The inclusion of the anti-inflammatory drug, Nabumetone, in α-, β-and hydroxypropylβ-cyclodextrin (CDs) is studied using UV-VIS absorption and steady-state fluorescence emission. Binding constants and thermodynamic parameters of complex formation are determined by spectrofluorimetry. The inclusion phenomena of Nabumetone with the three cyclodextrins is compared with that of the well known similar anti-inflammatory drug Naproxen. In the case of Nabumetone pronounced differences are observed in the complexation process with each cyclodextrin whereas the respective Naproxen complexes are nearly identical. 1H-NMR experiments show that the inclusion process in Nabumetone can occur either through the substituents in the -2 (butanone) or -6 (methoxy) positions in the naphthalene ring.es_ES
dc.format.mimetypeapplication/pdf
dc.language.isoenges_ES
dc.publisherSpringeres_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacionales_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/es_ES
dc.subjectNabumetonees_ES
dc.subjectNaproxenes_ES
dc.subjectCyclodextrines_ES
dc.subjectUV-absorption spectroscopyes_ES
dc.subjectFluorescence spectroscopyes_ES
dc.subjectThermodynamicses_ES
dc.subjectProton NMRes_ES
dc.subject.meshNaproxen *
dc.subject.meshCyclodextrins *
dc.subject.meshSpectrometry, Fluorescence *
dc.titleComplexation of the non-steroidal anti-inflammatory drug Nabumetone with modified and unmodified cyclodextrinses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publishversionhttps://doi.org/10.1023/A:1008011228459es_ES
dc.identifier.doi10.1023/A:1008011228459
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.essn1573-1111
dc.journal.titleJournal of inclusion phenomena and macrocyclic chemistryes_ES
dc.volume.number35es_ES
dc.issue.number4es_ES
dc.page.initial663es_ES
dc.page.final677es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES
dc.subject.decsciclodextrinas *
dc.subject.decsespectrometría de fluorescencia *
dc.subject.decsnaproxeno *


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional